See also this year's filing and all EDGAR filings for this company.
PDF Report 0000899866_2017_ALEXION_PHARMACEUTICALS_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0000899866')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000899866, ALEXION PHARMACEUTICALS INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,578,000,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 9,340,000,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,036,000,000 |
| 3 | remainder_Assets | 299,000,000 |
| 4 | LiabilitiesCurrent | 823,000,000 |
| 5 | LiabilitiesNoncurrent | 2,978,000,000 |
| 6 | remainder_Liabilities | 758,000,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 954,000,000 |
| 9 | ResearchAndDevelopmentExpense | 757,000,000 |
| 10 | remainder_Expenses | 980,000,000 |
| 11 | remainder_Revenues | 3,084,000,000 |
| 12 | remainder_NetIncome | 6,000,000 |
| 13 | remainder_ComprehensiveNetIncome | -2,000,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 13,253,000,000 |
| 1 | Liabilities | 4,559,000,000 |
| 2 | Expenses | 2,691,000,000 |
| 3 | Revenues | 3,084,000,000 |
| 4 | StockholdersEquity | 8,694,000,000 |
| 5 | NetIncome | 399,000,000 |
| 6 | ComprehensiveNetIncome | 398,000,000 |
| 7 | BaseVar | 11,797,500,000 |
| 8 | EconomicCapitalRatio | 1.72 |
Edgar->Model Mapping
Feature Distribution
